Back to Trades
HEALY JAMES
DirectorCIK 0001245624
Profile
- Filings
- 6
- Buy transactions
- 4
- Sell transactions
- 0
- Companies
- 4
- Active
- 2025–2026
HEALY JAMES, Director, accounts for 6 disclosed filings worth $42.4M, spread across 4 companies, active 2025–2026. The record is heavily weighted toward buying, with $20.4M in purchases against $0 in sales. The largest single open-market purchase on record is $20.4M in Rapport Therapeutics, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
6 loaded
| Oct 30 | RAPP Rapport Therapeutics, Inc. | HEALY JAMES | Director | Buy | $20.4M |
| Jun 12 | BIOA BioAge Labs, Inc. | HEALY JAMES | Insider | Award | $340.6K |
| Jun 10 | RAPP Rapport Therapeutics, Inc. | HEALY JAMES | Insider | Award | $535.2K |
| May 4 | SPTX Seaport Therapeutics, Inc. | HEALY JAMES | Insider | Conversion | $0 |
| Apr 30 | SPTX Seaport Therapeutics, Inc. | HEALY JAMES | Insider | Other | $0 |
| Sep 18 | YMAB Y-mAbs Therapeutics, Inc. | HEALY JAMES | Insider | Disposed | $21.1M |
6 filings